Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 1611028

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1611028

U.S. Medical Device Manufacturers Market Size, Share & Trends Analysis Report By Application, And Segment Forecasts, 2025 - 2030

PUBLISHED:
PAGES: 137 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

U.S. Medical Device Manufacturers Market Growth & Trends:

The U.S. medical device manufacturers market size is expected to reach USD 360.1 billion by 2030, registering a CAGR of 5.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. The regional market is significantly driven by the high healthcare expenditure of the country. The increasing geriatric population coupled with the rising prevalence of chronic diseases is also expected to augment the market growth over the forecast period.

The COVID-19 pandemic triggered a drastic rise in demand for medical consumables and patient aids, such as gloves, syringes, masks, PPE kits, infrared thermometers, pulse oximeter, testing kits, etc. This resulted in an immense opportunity for the existing players as well as new entrants. However, the pandemic also resulted in a massive reduction in elective procedures, such as bariatric surgeries, joint replacement surgeries, cosmetic surgeries, etc., thus restricting the growth of medical devices used in the aforementioned procedures. The market recovery can be expected from mid-2021 onwards with favorable government initiatives to re-launch elective procedures.

Growing investments in medical device R&D along with the high adoption rate of advanced technology in the U.S., create the perfect business environment for medical device manufacturers in the country, providing them with lucrative opportunities to accelerate their business operations. Increasing adoption of minimally invasive surgeries in the country is also driving the market. In addition, rising cases of accidental injuries coupled with diseases caused due to sedentary lifestyle will propel the market growth over the forecast period.

The U.S. has favorable reimbursement policies such as the U.S. Medicare system. Boston Scientific Corp., in association with the Centers for Medicare and Medicaid Services (CMS), offers reimbursement for all devices that fall under Ambulatory Payment Classifications (APCs), covered under C-codes. These favorable reimbursement structures are expected to fuel market growth; however, the ever-evolving nature of regulations may lead to abrupt amends, which may significantly impact the market.

U.S. Medical Device Manufacturers Market Report Highlights:

  • The others segment led the market and accounted for 35.7% of the revenue in 2024. The segment primarily comprises devices used in IVD diagnostics, medical imaging, dental, ear-nose-and-throat (ENT), wound care, and general surgery.
  • Cardiology devices are expected to register the fastest CAGR of 7.7% over the forecast period.
  • Heart diseases are one of the leading causes of mortality in the U.S. According to a CDC article published in May 2023, the high mortality, with one death due to cardiovascular disease every 33 seconds, creates a substantial market demand for innovative medical devices that can contribute to the prevention, early diagnosis, & effective treatment of heart-related conditions.
Product Code: GVR-3-68038-032-3

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application
    • 1.2.2. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in the U.S.
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Medical Device Manufacturers Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing geriatric population
      • 3.2.1.2. High adoption of minimally invasive procedures
      • 3.2.1.3. Increase in the number of sports and road accidents
      • 3.2.1.4. Increasing geographic reach of market players
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Increase in the number of product recalls
      • 3.2.2.2. Social and ethical issues
      • 3.2.2.3. Slow approval procedures
  • 3.3. U.S. Medical Device Manufacturers Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic Landscape

Chapter 4. U.S. Medical Device Manufacturers Market: Application Estimates & Trend Analysis

  • 4.1. Application Market Share, 2024 & 2030
  • 4.2. Segment Dashboard
  • 4.3. U.S. Medical Device Manufacturers Market by Application Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Orthopedic Devices
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.2. Cardiovascular Devices
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.3. Neurology Devices
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.4. Drug Delivery Devices
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.5. Ophthalmic Devices
      • 4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.6. Nephrology and Urology Devices
      • 4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.7. Others
      • 4.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 5. Competitive Landscape

  • 5.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 5.2. Company/Competition Categorization
  • 5.3. Vendor Landscape
    • 5.3.1. Key company market share analysis, 2024
    • 5.3.2. Stryker
      • 5.3.2.1. Company overview
      • 5.3.2.2. Financial performance
      • 5.3.2.3. Product benchmarking
      • 5.3.2.4. Strategic initiatives
    • 5.3.3. Cardinal Health
      • 5.3.3.1. Company overview
      • 5.3.3.2. Financial performance
      • 5.3.3.3. Product benchmarking
      • 5.3.3.4. Strategic initiatives
    • 5.3.4. Eli Lily and Company
      • 5.3.4.1. Company overview
      • 5.3.4.2. Financial performance
      • 5.3.4.3. Product benchmarking
      • 5.3.4.4. Strategic initiatives
    • 5.3.5. Intuitive Surgical
      • 5.3.5.1. Company overview
      • 5.3.5.2. Financial performance
      • 5.3.5.3. Product benchmarking
      • 5.3.5.4. Strategic initiatives
    • 5.3.6. Edwards Lifesciences Corporation
      • 5.3.6.1. Company overview
      • 5.3.6.2. Financial performance
      • 5.3.6.3. Product benchmarking
      • 5.3.6.4. Strategic initiatives
    • 5.3.7. BD
      • 5.3.7.1. Company overview
      • 5.3.7.2. Financial performance
      • 5.3.7.3. Product benchmarking
      • 5.3.7.4. Strategic initiatives
    • 5.3.8. Danaher
      • 5.3.8.1. Company overview
      • 5.3.8.2. Financial performance
      • 5.3.8.3. Product benchmarking
      • 5.3.8.4. Strategic initiatives
    • 5.3.9. 3M
      • 5.3.9.1. Company overview
      • 5.3.9.2. Financial performance
      • 5.3.9.3. Product benchmarking
      • 5.3.9.4. Strategic initiatives
    • 5.3.10. Abbott
      • 5.3.10.1. Company overview
      • 5.3.10.2. Financial performance
      • 5.3.10.3. Product benchmarking
      • 5.3.10.4. Strategic initiatives
    • 5.3.11. Baxter
      • 5.3.11.1. Company overview
      • 5.3.11.2. Financial performance
      • 5.3.11.3. Product benchmarking
      • 5.3.11.4. Strategic initiatives
    • 5.3.12. B. Braun SE
      • 5.3.12.1. Company overview
      • 5.3.12.2. Financial performance
      • 5.3.12.3. Product benchmarking
      • 5.3.12.4. Strategic initiatives
    • 5.3.13. GE HealthCare
      • 5.3.13.1. CompanOverviewew
      • 5.3.13.2. Financial performance
      • 5.3.13.3. Product benchmarking
      • 5.3.13.4. Strategic initiatives
    • 5.3.14. Johnson & Johnson Services, Inc.
      • 5.3.14.1. CompanOverviewew
      • 5.3.14.2. Financial performance
      • 5.3.14.3. Product benchmarking
      • 5.3.14.4. Strategic initiatives
    • 5.3.15. Medtronic
      • 5.3.15.1. Company overview
      • 5.3.15.2. Financial performance
      • 5.3.15.3. Product benchmarking
      • 5.3.15.4. Strategic initiatives
    • 5.3.16. Boston Scientific Corporation
      • 5.3.16.1. CompanOverviewew
      • 5.3.16.2. Financial performance
      • 5.3.16.3. Product benchmarking
      • 5.3.16.4. Strategic initiatives
Product Code: GVR-3-68038-032-3

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. Medical Device Manufacturers market revenue estimates and forecast, by application, 2018 - 2030 (USD Billion)
  • Table 4 Key companies undergoing acquisitions/expansions
  • Table 5 Key companies undergoing product launch/approval
  • Table 6 Key companies undergoing partnership & collaboration

List of Figures

  • Fig. 1 U.S. Medical Device Manufacturers Market Segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market snapshot
  • Fig. 8 Competitive landscape
  • Fig. 9 Market Dynamics
  • Fig. 10 U.S. Medical Device Manufacturers market: PORTER's analysis
  • Fig. 11 U.S. Medical Device Manufacturers market: PESTEL analysis
  • Fig. 12 U.S. Medical Device Manufacturers market: by application: key takeaways
  • Fig. 13 U.S. Medical Device Manufacturers market, by application: market share, 2024 & 2030
  • Fig. 14 Orthopedic devices market, 2018 - 2030 (USD Billion)
  • Fig. 15 Cardiovascular devices market, 2018 - 2030 (USD Billion)
  • Fig. 16 Neurology devices market, 2018 - 2030 (USD Billion)
  • Fig. 17 Drug delivery devices market, 2018 - 2030 (USD Billion)
  • Fig. 18 Ophthalmic devices market, 2018 - 2030 (USD Billion)
  • Fig. 19 Nephrology and urology devices market, 2018 - 2030 (USD Billion)
  • Fig. 20 Others market, 2018 - 2030 (USD Billion)
  • Fig. 21 Key company categorization
  • Fig. 22 Heat map analysis
  • Fig. 23 U.S orthopedic devices market share analysis, 2024
  • Fig. 24 U.S cardiac care devices market share analysis, 2024
  • Fig. 25 U.S drug delivery devices market share analysis, 2024
  • Fig. 26 Strategic Framework
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!